Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism

Orphanet Journal of Rare Diseases

Volumn 5, Issue 1, 2010, Pages

  Amar, Laurence ^a   Plouin, Pierre François ^a   Steichen, Olivier ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANTIHYPERTENSIVE AGENT; DEOXYCORTICOSTERONE; EPLERENONE; GLYCYRRHIZIC ACID; HYDROCORTISONE; MINERALOCORTICOID; RENIN; SPIRONOLACTONE;

ADENOMA; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL HYPERPLASIA; ADRENALECTOMY; ALDOSTERONE RELEASE; ALDOSTERONE SECRETING ADENOMA; ALDOSTERONOMA; BLOOD PRESSURE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONN ADENOMA; DEXAMETHASONE SUPPRESSION TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILY HISTORY; HUMAN; HYPERTENSION; HYPOKALEMIA; LAPAROSCOPIC SURGERY; LIDDLE SYNDROME; MORBIDITY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PSEUDOHYPERALDOSTERONISM; REVIEW; SCREENING TEST; SUPRARENAL VEIN; VEIN; HYPERALDOSTERONISM; METABOLISM;

ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ALDOSTERONE; HUMANS; HYPERALDOSTERONISM;

EID: 77952307464     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-5-9     Document Type: Review

References (83)

1. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. JW Conn, J Lab Clin Med 1955 45 3 17 13233623
2. Suppression of Plasma Renin Activity in Primary Aldosteronism. JW Conn EL Cohen DR Rovner, Jama 1964 190 213 21 14246592
3. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. JW Funder RM Carey C Fardella,, et al. J Clin Endocrinol Metab 2008 93 3266 81 10.1210/jc.2008-0104 18552288
4. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. C Newton-Cheh CY Guo P Gona,, et al. Hypertension 2007 49 846 56 10.1161/01.HYP.0000258554.87444.91 17296870
5. Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. T Nishikawa M Omura, Biomed Pharmacother 2000 54 Suppl 1 83s 5s 10.1016/S0753-3322(00)80019-0 10914999
6. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. P Mulatero M Stowasser KC Loh,, et al. J Clin Endocrinol Metab 2004 89 1045 50 10.1210/jc.2003-031337 15001583
7. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. GP Rossi G Bernini C Caliumi,, et al. J Am Coll Cardiol 2006 48 2293 300 10.1016/j.jacc.2006.07.059 17161262
8. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. R Fogari P Preti A Zoppi A Rinaldi E Fogari A Mugellini, Hypertens Res 2007 30 111 7 10.1291/hypres.30.111 17460380
9. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. S Douma K Petidis M Doumas,, et al. Lancet 2008 371 1921 6 10.1016/S0140-6736(08)60834-X 18539224
10. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. E Rossi G Regolisti A Negro C Sani S Davoli F Perazzoli, Am J Hypertens 2002 15 896 902 10.1016/S0895-7061(02)02969-2 12372677
11. Global burden of hypertension: analysis of worldwide data. PM Kearney M Whelton K Reynolds P Muntner PK Whelton J He, Lancet 2005 365 217 23 15652604
12. Conn syndrome in a child, caused by adrenal adenoma. A Abasiyanik B Oran A Kaymakci C Yasar U Caliskan I Erkul, J Pediatr Surg 1996 31 430 2 10.1016/S0022-3468(96)90753-8 8708918
13. The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. GS Andersen DB Toftdahl JO Lund S Strandgaard PE Nielsen, J Hum Hypertens 1988 2 187 9 3236322
14. Epidemiologic study of adrenal gland disorders in Japan. R Takayanagi K Miura H Nakagawa H Nawata, Biomed Pharmacother 2000 54 Suppl 1 164s 8s 10.1016/S0753-3322(00)80036-0 10915016
15. Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. T Obara Y Ito T Okamoto,, et al. Surgery 1992 112 987 93 1455323
16. Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia. PE Gleason MH Weinberger JH Pratt,, et al. J Urol 1993 150 1365 8 8411401
17. Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? CA Proye EA Mulliez BM Carnaille,, et al. Surgery 1998 124 1128 33 10.1067/msy.1998.93108 9854594
18. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. AM Sawka WF Young GB Thompson,, et al. Ann Intern Med 2001 135 258 61 11511140
19. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. F Lumachi M Ermani SM Basso D Armanini M Iacobone G Favia, Am Surg 2005 71 864 9 16468537
20. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. TC Pang C Bambach JC Monaghan,, et al. ANZ J Surg 2007 77 768 73 10.1111/j.1445-2197.2007. 04225.x 17685956
21. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. GP Rossi M Bolognesi D Rizzoni,, et al. Hypertension 2008 51 1366 71 10.1161/HYPERTENSIONAHA.108.111369 18347224
22. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. E Letavernier S Peyrard L Amar F Zinzindohoue B Fiquet PF Plouin, J Hypertens 2008 26 1816 23 10.1097/HJH.0b013e3283060f0c 18698217
23. Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy? R Zarnegar AI Bloom J Lee,, et al. J Vasc Interv Radiol 2008 19 66 71 10.1016/j.jvir.2007.08.022 18192469
24. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. R Zarnegar WF Young Jr J Lee,, et al. Ann Surg 2008 247 511 8 10.1097/SLA.0b013e318165c075 18376197
25. Hyperaldosteronism among black and white subjects with resistant hypertension. DA Calhoun MK Nishizaka MA Zaman RB Thakkar P Weissmann, Hypertension 2002 40 892 6 10.1161/01.HYP.0000040261.30455.B6 12468575
26. -2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. G Mancia G De Backer A Dominiczak,, et al. J Hypertens 2007 25 1751 62 10.1097/HJH.0b013e3282f0580f 17762635
27. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases. V Medeau F Moreau L Trinquart,, et al. Clin Endocrinol (Oxf) 2008 69 20 8 10.1111/j.1365-2265.2008. 03213.x 18284637
28. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. F Mantero M Terzolo G Arnaldi,, et al. J Clin Endocrinol Metab 2000 85 637 44 10.1210/jc.85.2.637 10690869
29. Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. GP Rossi TM Seccia G Palumbo,, et al. Hypertension 2009 55 83 9 10.1161/HYPERTENSIONAHA.109.139832 19933925
30. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. A Tanabe M Naruse S Takagi K Tsuchiya T Imaki K Takano, J Clin Endocrinol Metab 2003 88 2489 94 10.1210/jc.2002-021476 12788844
31. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. K Hiramatsu T Yamada Y Yukimura,, et al. Arch Intern Med 1981 141 1589 93 10.1001/archinte.141.12.1589 7030245
32. Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. DJ Campbell J Nussberger M Stowasser,, et al. Clin Chem 2009 55 867 77 10.1373/clinchem.2008.118000 19264850
33. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. VM Montori WF Young Jr, Endocrinol Metab Clin North Am 2002 31 619 32 xi. 10.1016/S0889-8529(02)00013-0 12227124
34. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. BJ Gallay S Ahmad L Xu B Toivola RC Davidson, Am J Kidney Dis 2001 37 699 705 10.1016/S0272-6386(01)80117-7 11273868
35. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. P Mulatero F Rabbia A Milan,, et al. Hypertension 2002 40 897 902 10.1161/01.HYP.0000038478.59760.41 12468576
36. New mechanisms to control aldosterone synthesis. HS Willenberg S Schinner I Ansurudeen, Horm Metab Res 2008 40 435 41 10.1055/s-2008-1065336 18493881
37. Laboratory diagnosis of primary aldosteronism, and drospirenone- ethinylestradiol therapy. F Pizzolo C Pavan R Corrocher O Olivieri, Am J Hypertens 2007 20 1334 7 10.1016/j.amjhyper.2007.08.009 18047926
38. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. RD Gordon CE Gomez-Sanchez SM Hamlet TJ Tunny SA Klemm, J Hypertens Suppl 1987 5 103 6 2832571
39. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. I Irony CE Kater EG Biglieri CH Shackleton, Am J Hypertens 1990 3 576 82 2194512
40. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. GP Rossi A Belfiore G Bernini,, et al. J Hypertens 2007 25 1433 42 10.1097/HJH.0b013e328126856e 17563566 (Pubitemid 46918831)
41. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. JS Williams GH Williams A Raji,, et al. J Hum Hypertens 2006 20 129 36 10.1038/sj.jhh.1001948 16292348
42. Primary aldosteronism: renaissance of a syndrome. WF Young, Clin Endocrinol (Oxf) 2007 66 607 18 10.1111/j.1365-2265.2007.02775.x 17492946
43. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. D Hirohara K Nomura T Okamoto M Ujihara K Takano, J Clin Endocrinol Metab 2001 86 4292 8 10.1210/jc.86.9.4292 11549664
44. Primary aldosteronism - careful investigation is essential and rewarding. M Stowasser RD Gordon, Mol Cell Endocrinol 2004 217 33 9 10.1016/j.mce.2003.10. 006 15134798
45. Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. F Lumachi MC Marzola P Zucchetta,, et al. Nucl Med Commun 2003 24 683 8 10.1097/00006231-200306000-00011 12766605
46. The size of normal adrenal glands on computed tomography. JM Vincent ID Morrison P Armstrong RH Reznek, Clin Radiol 1994 49 453 5 10.1016/S0009-9260(05) 81739-8 8088036
47. The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. ML White PG Gauger GM Doherty,, et al. Surgery 2008 144 926 33 discussion 33. 10.1016/j.surg.2008.07.025 19040999
48. The clinically inapparent adrenal mass: update in diagnosis and management. G Mansmann J Lau E Balk M Rothberg Y Miyachi SR Bornstein, Endocr Rev 2004 25 309 40 10.1210/er.2002-0031 15082524
49. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. MJ Kempers JW Lenders L van Outheusden,, et al. Ann Intern Med 2009 151 329 37 19721021
50. Role for adrenal venous sampling in primary aldosteronism. WF Young AW Stanson GB Thompson CS Grant DR Farley JA van Heerden, Surgery 2004 136 1227 35 10.1016/j.surg.2004.06.051 15657580
51. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. C Gicquel X Bertagna V Gaston,, et al. Cancer Res 2001 61 6762 7 11559548
52. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. GP Rossi C Ganzaroli D Miotto,, et al. J Hypertens 2006 24 371 9 10.1097/01.hjh.0000202818.10459.96 16508586
53. Adrenal vein sampling: how to make it quick, easy, and successful. N Daunt, Radiographics 2005 25 Suppl 1 143 58 10.1148/rg.25si055514 16227488
54. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. SB Magill H Raff JL Shaker,, et al. J Clin Endocrinol Metab 2001 86 1066 71 10.1210/jc.86.3.1066 11238487
55. Hyperaldosteronism: sampling the adrenal veins. JL Doppman JR Gill Jr, Radiology 1996 198 309 12 8596821
56. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? WF Young AW Stanson, Clin Endocrinol (Oxf) 2009 70 14 7 10.1111/j.1365-2265.2008.03450.x 19128364
57. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. M Omura H Sasano T Fujiwara K Yamaguchi T Nishikawa, Metabolism 2002 51 350 5 10.1053/meta.2002.30498 11887172
58. Mineralocorticoid hypertension. PM Stewart, Lancet 1999 353 1341 7 10.1016/S0140-6736(98)06102-9 10218547
59. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. BM Biller AB Grossman PM Stewart,, et al. J Clin Endocrinol Metab 2008 93 2454 62 10.1210/jc.2007-2734 18413427
60. [11beta-hydroxysteroide dehydrogenases. Recent advances]. MC Vantyghem S Marcelli-Tourvieille F Defrance JL Wemeau, Ann Endocrinol (Paris) 2007 68 349 56 17368420
61. Liddle syndrome: genetics and mechanisms of Na+ channel defects. DG Warnock, Am J Med Sci 2001 322 302 7 10.1097/00000441-200112000-00002 11780687
62. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. L Pascoe X Jeunemaitre MC Lebrethon,, et al. J Clin Invest 1995 96 2236 46 10.1172/JCI118279 7593610
63. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. P Milliez X Girerd PF Plouin J Blacher ME Safar JJ Mourad, J Am Coll Cardiol 2005 45 1243 8 10.1016/j.jacc.2005.01.015 15837256
64. Long-term renal outcomes in patients with primary aldosteronism. LA Sechi M Novello R Lapenna,, et al. Jama 2006 295 2638 45 10.1001/jama.295.22.2638 16772627
65. A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. JM Connell SM MacKenzie EM Freel R Fraser E Davies, Endocr Rev 2008 29 133 54 10.1210/er.2007-0030 18292466
66. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. J Matrozova O Steichen L Amar S Zacharieva X Jeunemaitre PF Plouin, Hypertension 2009 53 605 10 10.1161/HYPERTENSIONAHA.108.122002 19221213
67. Cardiovascular outcomes in patients with primary aldosteronism after treatment. C Catena G Colussi E Nadalini,, et al. Arch Intern Med 2008 168 80 5 10.1001/archinternmed.2007.33 18195199
68. Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. YW Novitsky KW Kercher MJ Rosen WS Cobb S Jyothinagaram BT Heniford, Surgery 2005 138 1009 16 10.1016/j.surg.2005.09.027 16360385
69. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. S Ishidoya A Ito K Sakai,, et al. J Urol 2005 174 40 3 10.1097/01.ju.0000162045.68387.c3 15947573
70. Laparoscopic adrenalectomy. A Assalia M Gagner, Br J Surg 2004 91 1259 74 10.1002/bjs.4738 15376201
71. [Adrenal tumors]. MK Walz, Chirurg 2008 79 1087 94 10.1007/s00104-008- 1638-z 18941729
72. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma. R Zarnegar J Lee L Brunaud,, et al. Surgery 2007 142 921 9 discussion -9. 10.1016/j.surg.2007.09.001 18063077
73. Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism. WT Shen RC Lim AE Siperstein,, et al. Arch Surg 1999 134 628 31 10.1001/archsurg.134.6.628 10367872
74. Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness. M Stowasser SA Klemm TJ Tunny WJ Storie JC Rutherford RD Gordon, Clin Exp Pharmacol Physiol 1994 21 319 22 10.1111/j.1440-1681.1994.tb02520.x 7923899
75. Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. K Nomura S Toraya N Horiba M Ujihara M Aiba H Demura, J Clin Endocrinol Metab 1992 75 323 7 10.1210/jc.75.1.323 1619026
76. Diagnosis and treatment of primary hyperaldosteronism. JD Blumenfeld JE Sealey Y Schlussel,, et al. Ann Intern Med 1994 121 877 85 7978702
77. Medical management of aldosterone-producing adenomas. RP Ghose PM Hall EL Bravo, Ann Intern Med 1999 131 105 8 10419425
78. Efficacy and tolerance of spironolactone in essential hypertension. X Jeunemaitre G Chatellier C Kreft-Jais,, et al. Am J Cardiol 1987 60 820 5 10.1016/0002-9149(87)91030-7 3661395
79. Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. P Meria BF Kempf JF Hermieu PF Plouin JM Duclos, J Urol 2003 169 32 5 10.1016/S0022-5347(05)64028-1 12478096
80. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. P Mulatero C Bertello D Rossato,, et al. J Clin Endocrinol Metab 2008 93 1366 71 10.1210/jc.2007-2055 18198224
81. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. EA Espiner DG Ross TG Yandle AM Richards PJ Hunt, J Clin Endocrinol Metab 2003 88 3637 44 10.1210/jc.2002-022051 12915648
82. Change in the pattern of adrenal venous sampling over time in patients with primary aldosteronism. M Murashima SO Trerotola DL Fraker D Han RR Townsend DL Cohen, J Hum Hypertens 2009 23 292 4 10.1038/jhh.2008.108 18754018
83. Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism. RJ Auchus C Michaelis FH Wians Jr,, et al. Ann Surg 2009 249 318 21 10.1097/SLA.0b013e3181961d77 19212188